"Cardiotoxicity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Damage to the heart or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
Descriptor ID |
D066126
|
MeSH Number(s) |
C23.550.161 C25.100.389 C26.733.266 G01.750.748.500.266
|
Concept/Terms |
Cardiotoxicity- Cardiotoxicity
- Cardiotoxicities
- Cardiac Toxicity
- Cardiac Toxicities
- Toxicities, Cardiac
- Toxicity, Cardiac
|
Below are MeSH descriptors whose meaning is more general than "Cardiotoxicity".
Below are MeSH descriptors whose meaning is more specific than "Cardiotoxicity".
This graph shows the total number of publications written about "Cardiotoxicity" by people in this website by year, and whether "Cardiotoxicity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2018 | 0 | 2 | 2 |
2019 | 0 | 2 | 2 |
2021 | 0 | 1 | 1 |
2022 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiotoxicity" by people in Profiles.
-
Emerging mitochondrial signaling mechanisms in cardio-oncology: beyond oxidative stress. Am J Physiol Heart Circ Physiol. 2022 10 01; 323(4):H702-H720.
-
Pulling back the curtain on anthracycline cardiotoxicity: the hidden role of the microcirculation. Cardiovasc Res. 2022 01 29; 118(2):347-349.
-
Endothelial dysfunction as a complication of anti-cancer therapy. Pharmacol Ther. 2022 09; 237:108116.
-
Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association. Circ Res. 2021 06 25; 129(1):e21-e34.
-
Detrimental effects of chemotherapy on human coronary microvascular function. Am J Physiol Heart Circ Physiol. 2019 10 01; 317(4):H705-H710.
-
Cancer therapy-induced cardiovascular toxicity: old/new problems and old drugs. Am J Physiol Heart Circ Physiol. 2019 07 01; 317(1):H164-H167.
-
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial. Ann Oncol. 2018 08 01; 29(8):1777-1783.
-
Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress. Int J Mol Sci. 2018 Mar 10; 19(3).